Vera Therapeutics (VERA) Capital Expenditures (2020 - 2026)
Vera Therapeutics (VERA) posted Capital Expenditures of $23000.0 for Q1 2026, down 77.45% on a QoQ basis from $102000.0 in Q4 2025, and down 87.7% year-over-year from $187000.0 in Q1 2025.
Vera Therapeutics (VERA) Capital Expenditures (2020 - 2026) Analysis & Trends
Vera Therapeutics' Capital Expenditures history runs 6 years deep, the most recent figure standing at $23000.0 for Q1 2026.
- Quarterly Capital Expenditures fell 87.7% year-over-year to $23000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $466000.0 (down 59.79% YoY) and the FY2025 annual result came in at $630000.0, down 35.19% from the prior year.
- Capital Expenditures was $23000.0 for Q1 2026 at Vera Therapeutics, down from $102000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $645000.0 in Q4 2024 and bottomed at $6000.0 in Q2 2022.
- A 5-year average of $145833.3 and a median of $95500.0 in 2024 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2024 — Capital Expenditures jumped 923.81% — and 2026, when it slumped 87.7%.
- Vera Therapeutics' Capital Expenditures stood at $38000.0 in 2022, then soared by 65.79% to $63000.0 in 2023, then soared by 923.81% to $645000.0 in 2024, then sank by 84.19% to $102000.0 in 2025, then tumbled by 77.45% to $23000.0 in 2026.
- Business Quant data shows VERA's Capital Expenditures at $23000.0 in Q1 2026, $102000.0 in Q4 2025, and $133000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Vera Therapeutics | 2.60 Bn | 2.60 Bn | - | 23,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23,000.00 |
| Mar 31, 2026 | 23,000.00 |
| Dec 31, 2025 | 102,000.00 |
| Dec 31, 2025 | 102,000.00 |
| Sep 30, 2025 | 133,000.00 |
| Sep 30, 2025 | 133,000.00 |
| Jun 30, 2025 | 208,000.00 |
| Jun 30, 2025 | 208,000.00 |
| Mar 31, 2025 | 187,000.00 |
| Mar 31, 2025 | 187,000.00 |
| Dec 31, 2024 | 645,000.00 |
| Dec 31, 2024 | 645,000.00 |
| Sep 30, 2024 | 238,000.00 |
| Sep 30, 2024 | 238,000.00 |
| Jun 30, 2024 | 89,000.00 |
| Jun 30, 2024 | 89,000.00 |
| Dec 31, 2023 | 63,000.00 |
| Dec 31, 2023 | 63,000.00 |
| Sep 30, 2022 | 38,000.00 |
| Sep 30, 2022 | 38,000.00 |